Century Therapeutics
IPSC
Century Therapeutics (IPSC) analyst forecast and price target
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Mizuho | Initiated Coverage | Outperform | $8.00 | May 27, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $5.00 from $2.00 | Apr 21, 2026 |
| Piper Sandler | Maintained | Overweight | $4.00 from $2.00 | Jan 20, 2026 |
| Leerink Partners | Downgraded | Outperform → Market Perform | $2.00 from $7.00 | Nov 17, 2025 |
| Chardan Capital | Maintained | Buy | $6.00 from $7.00 | May 16, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $2.00 from $5.00 | Apr 3, 2025 |
| Guggenheim | Maintained | Buy | — | Mar 28, 2025 |
| Chardan Capital | Maintained | Buy | $7.00 from $11.00 | Mar 24, 2025 |
| Guggenheim | Maintained | Buy | $5.00 from $12.00 | Mar 21, 2025 |
| Piper Sandler | Maintained | Overweight | $2.00 from $4.00 | Mar 20, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $5.00 | Jan 22, 2025 |
| Guggenheim | Maintained | Buy | — | Jan 22, 2025 |
| Piper Sandler | Maintained | Overweight | $4.00 from $12.00 | Dec 30, 2024 |
| Chardan Capital | Maintained | Buy | $11.00 from $17.00 | Nov 7, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $5.00 from $9.00 | Nov 6, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $9.00 from $11.00 | Aug 15, 2024 |
| Piper Sandler | Maintained | Overweight | $12.00 from $9.00 | Jun 17, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $11.00 | Jun 4, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $11.00 from $13.00 | May 10, 2024 |
| Piper Sandler | Maintained | Overweight | $9.00 from $10.00 | Apr 12, 2024 |
Frequently asked questions
What is the latest analyst rating on IPSC?
On May 27, 2026, Mizuho initiated coverage of Century Therapeutics at Outperform with a price target of $8.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.